Health Policy Negative 6

Prior Auth Denials Hit 12–18% Across Public Plans; 67% Overturned in MA

KFF's first analysis of mandatory 2026 prior authorization reporting reveals wide variation in denial rates across Medicare Advantage, Medicaid, and ACA Marketplace plans, with 12%-18% of standard requests denied and most appealed denials overturned. For healthcare leaders, the data expose care access barriers and administrative friction that vary sharply by insurer.

· 4 min read ·

Beat this week

Last 7 days · Health Policy

25 stories
5.6 avg impact
4% positive
24% negative
vs prior 7 days -17 -17 stories vs prior 7 days

Impact 5.6/10, unchanged. Counts are stories in our record, not a market forecast.

Open the change report

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 20 percentage points.

  • 4% positive
  • 72% neutral
  • 24% negative

This story sits in Health Policy — the counts compare this beat's last 7 days with the previous 7 in our verified record, not a market forecast.

Figures are computed live from our source-verified story record (as of ) The volume change compares this window with the prior 7 days in the same record. — see our methodology for how impact and sentiment are derived.

Healthcare briefing

Key takeaways

6 impact
Negativesentiment
4min read
  1. KFF's first analysis of mandatory 2026 prior authorization reporting reveals wide variation in denial rates across Medicare Advantage, Medicaid, and ACA Marketplace plans, with 12%-18% of standard requests denied and most appealed denials overturned.
  2. For healthcare leaders, the data expose care access barriers and administrative friction that vary sharply by insurer.

In this briefing

Mentioned

Key Intelligence

Key Facts

  1. 1At least 1 in 8 standard prior authorization requests across Medicare Advantage, Medicaid managed care, and ACA Marketplace plans were denied in 2025.
  2. 2Overall standard denial rates were 12% for Medicare Advantage and 18% for ACA Marketplace coverage.
  3. 3Among large Medicare Advantage insurers, denial rates ranged from 5% at Elevance to 17% at UnitedHealth Group.
  4. 4ACA Marketplace standard denial rates ranged from 3% at GuideWell to 25% at Centene.
  5. 5Appeals overturned 67% of Medicare Advantage denials, 47% of Medicaid managed care denials, and 43% of ACA Marketplace denials, though appeals remain rare.
  6. 6Most requests were approved—82% to 90% depending on plan type—and insurers report median standard request response times of about one day.
Plan Type
Medicare Advantage 12% overall; 5%–17% by top insurers 67%
Medicaid Managed Care 2%–23% by insurer 47%
ACA Marketplace 18% overall; 3%–25% by insurer 43%

Who's Affected

UnitedHealth Group
companyNegative
Centene
companyNegative
Elevance Health
companyPositive
CMS
governmentPositive

Analysis

For clinicians, hospital administrators, and health IT teams, the KFF report converts a long-standing frustration into hard numbers: at least one in eight prior authorization requests are denied, and appeal overturns as high as 67% in Medicare Advantage suggest many initial denials are medically unnecessary. The wide variation among insurers offering the same public coverage means patients in nearly identical clinical situations can face drastically different access depending on their plan.

On August 14, 2026, KFF released its first analysis of newly mandated prior authorization data from the nation's major government-subsidized insurance programs, revealing that health insurers denied at least one in eight standard prior authorization requests in 2025. Across Medicare Advantage, Medicaid managed care, and Affordable Care Act Marketplace plans, standard requests were denied at overall rates of 12 percent for Medicare Advantage and 18 percent for ACA Marketplace coverage. The figures mark the initial baseline under a 2026 Centers for Medicare & Medicaid Services transparency rule that requires insurers to publicly report prior authorization metrics.

The KFF analysis found that 67 percent of denied Medicare Advantage prior authorization requests were overturned when appealed, along with 47 percent in Medicaid managed care and 43 percent in ACA Marketplace plans.

The report found dramatic variation among insurers that operate in the same programs. In Medicare Advantage, standard denial rates for the largest plans ranged from 5 percent at Elevance to 17 percent at UnitedHealth Group. In Medicaid managed care, L.A. Care Health Plan denied 2 percent of standard requests while Independence Health Group denied 23 percent. In ACA Marketplace plans, GuideWell denied just 3 percent while Centene denied 25 percent. Expedited requests, which are supposed to be processed for urgent needs, were denied at similar or slightly lower rates, indicating that even time-sensitive care faced substantial friction in some plans.

The data are significant because they are the first to be published under CMS's 2026 reporting mandate, a federal effort to make prior authorization practices more transparent and comparable. Overall, most requests were approved—between 82 percent and 90 percent depending on plan type—yet a 12 to 18 percent denial rate translates into millions of delayed or blocked services across three programs that cover tens of millions of Americans. The wide gap between the lowest and highest denial rates suggests that some insurers may be applying more restrictive clinical review criteria or relying more heavily on automated decisioning, while others take a more permissive approach.

The most striking finding is what happens on appeal. The KFF analysis found that 67 percent of denied Medicare Advantage prior authorization requests were overturned when appealed, along with 47 percent in Medicaid managed care and 43 percent in ACA Marketplace plans. The fact that most appeals reverse the initial denial raises serious questions about the accuracy and fairness of the initial review process. However, appeals remain rare, which means many patients and providers may simply absorb the denial or abandon care rather than contest it. Industry group AHIP said median response times for standard requests are about one day, much faster than federal timeframes, and emphasized that the vast majority of requests are approved quickly.

What to Watch

For the managed care sector, the new public data create a fresh reputational and regulatory risk metric. Insurers with outlier denial rates—especially UnitedHealth Group in Medicare Advantage and Centene in the ACA Marketplace—may face scrutiny from state and federal regulators, consumer advocates, and providers. Elevance and GuideWell, which posted some of the lowest denial rates, may use the results as a competitive advantage in plan quality marketing. Investors will watch whether high denial rates translate into enforcement actions, network disputes, or changes in member retention.

Looking ahead, the 2026 reporting mandate likely represents the beginning rather than the end of prior authorization oversight. High appeal overturn rates could prompt CMS or states to require automatic review of certain denials, impose penalties for repeated inappropriate denials, or set public reporting thresholds. The data also raise questions about the role of algorithms and artificial intelligence in utilization management, an area already under congressional and regulatory scrutiny. The 2025 baseline will be used to measure whether transparency alone changes insurer behavior, or whether stricter rules will be needed to reduce inappropriate barriers to care.

Cite This Page

"Prior Auth Denials Hit 12–18% Across Public Plans; 67% Overturned in MA." Healthcare Intelligence Brief, August 14, 2026. https://gethealthbrief.com/story/health-prior-auth-denials-kff-2026

How we covered this story

Every story in our healthcare coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the healthcare space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.

Sources are only linked to a story once they clear our classification pipeline at a minimum 35 percent relevance threshold. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.

See something wrong in this story — a wrong fact, a broken source link, a misattributed entity? Report a data issue.